This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.
Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing.
In the first few weeks of open enrollment, new signups on the healthcare marketplace, healthcare.gov, are up nearly 40%, according to the Department of Health and Human Services (HHS).
Kaiser Permanente staved off what would have been the largest private-sector nursing strike after reaching an agreement with 21,000 unionized Northern California nurses.
Health Exec caught up with Brian Clear, MD, chief medical officer with Bicycle Health, to learn more about the current state of the opioid overdose crisis and the role of telehealth.
The Centers for Medicare and Medicaid Services (CMS) is charging forward with its plan to bring Medicare and Medicaid beneficiaries into coordinated care models.
U.S. physicians might be missing out on innovative medical research due to the overwhelming amount of reading and clinical work they are faced with, according to a recent survey.
Patients with diabetes faced a much higher risk of a cardiovascular event in 1994 than they did in 2014, according to a new analysis published in JAMA.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.
Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing.